EVOMMUNE INC

EVMN · NYSE

Updated at 2026-10-15 09:50:37

$5.77-1.87%
Today's High
$5.96
Today’s Low
$5.64
EVOMMUNE INC (EVMN) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$6.09
Previous Close
$6.05
Volume
384.15K
Market Cap
$209.4M
P/E Ratio
--
EPS
$-3.82

Previous Day Range

$6.04$6.22

52-Week Range

$5.85$33.20

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
1891 PAGE MILL ROAD, PALO ALTO, CA, UNITED STATES, 94304
Country
US
Listing Date
2025-11-06
Fiscal Year End
December
Shares Outstanding
36.02M
CIK
--

Evommune, Inc. is an innovative biotechnology company focused on developing cutting-edge therapeutics for immunological disorders, targeting significant unmet medical needs in this critical sector. With a promising pipeline and advanced research methodologies, Evommune is positioned to enhance immune response and improve patient outcomes. The company aims to establish a leading presence in the evolving immunotherapy market through its commitment to robust scientific practices and strategic partnerships. As it progresses through clinical trials, Evommune is striving to deliver transformative solutions that could redefine the standards of care in immunology, thereby significantly impacting patient quality of life.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

$0

2025-09-30

$10M

Operating Expenses

2026-06-30

$34.89M

2026-03-31

$23.6M

2025-12-31

$29.71M

2025-09-30

$23.32M

Net Income

2026-06-30

-$32.24M

2026-03-31

-$21.67M

2025-12-31

-$28.27M

2025-09-30

-$12.47M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

-124.75%

Earnings Per Share

2026-06-30

$-0.89

2026-03-31

$-0.64

2025-12-31

$-1.43

2025-09-30

$-8.07

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$34.34M

2026-03-31

-$21.32M

2025-12-31

-$27.94M

2025-09-30

-$12.16M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.